Breaking 12 cents, page-20

George, if Imugene ticks all the boxes and can remain independent it could be bigger than CSL. Yes, it is very possible to reach $1 per share. Timing is what we don't know.

In the unlikely event that all lines of treatment fail it could be worth very little.

Imugene, so far, continues to tick all the boxes.

I only invest what i can afford to lose. I never put my future at risk by getting in too deep. I now have 1.4 million shares and options and I have called a halt to buying regardless of what I think the share price will do. I can't afford to get in deeper.

You must invest based on your own situation and how well you can handle the share price fluctuations.

Always do your own research and take responsibility for your own investment decisions.

Not investment advice. DYOR